907208-90-6

Basic information

• Product Name: 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE
• Synonyms: 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE
• CAS NO: 907208-90-6
• Molecular Formula: C₉H₁₂FN₃
• Molecular Weight: 181.213
• Mol File: 907208-90-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE(907208-90-6)
• EPA Substance Registry System: 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE(907208-90-6)

Safety Data

• Hazardous Substances Data: 907208-90-6(Hazardous Substances Data)

Usage

General Description

1-(5-Fluoropyridin-2-yl)piperazine is a chemical compound with the molecular formula C10H13FN3. It is a piperazine derivative with a fluoropyridine group attached to the piperazine ring. 1-(5-FLUOROPYRIDIN-2-YL)PIPERAZINE is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential use as a ligand in coordination chemistry and as a building block for the development of new materials. However, it is important to handle this compound with care as it may pose hazards if not properly managed. Overall, 1-(5-Fluoropyridin-2-yl)piperazine has diverse applications and is an important building block in the chemical industry.

Upstream product

• 110-85-0 piperazine 
• 624-28-2 2,5-dibromopyridine 
• 41404-58-4 2-bromo-5-fluoropyridine 

Relevant articles and documents

Substituted pyrazole fused ring derivative as well as preparation method and application thereof

The invention relates to the field of medicinal chemistry, and mainly relates to a compound represented by a formula I, a stereoisomer, a despinner, a tautomer, an isotope marker, NOx or a pharmaceutically acceptable salt thereof, a preparation method of the compound, and an application of the compound in preparation of a medicine for treating RET kinase mediated diseases.

Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists

Disclosed are compounds of the formula or a pharmaceutically acceptable salt thereof, wherein: M1 and M3 are CH or N; M2 is CH, CF or N; Y is —C(═O)—, —C(═S)—, —(CH2)q—, —C(═NOR7)— or —SO1-2—; Z is a bond or optionally substituted alkylene or alkenylene; R1 is H, alkyl, alkenyl, or optionally substituted cycloalkyl, aryl, heteroaryl, heterocycloalkyl or a group of the formula: where ring A is a monoheteroaryl ring; R1 is optionally substituted alkyl, alkenyl, aryl, heteroaryl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; compositions and methods of treating allergy-induced airway responses, congestion, obesity, metabolic syndrome nonalcoholic fatty liver disease, hepatic steatosis, nonalcoholic steatohepatitis, cirrhosis, hepatacellular carcinoma or cognition deficit disorders using said compounds, alone or in combination with other agents.